Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Analytical and Clinical Performance Evaluation of the Elecsys HIV combi PT Assay on the cobas e 602 Analyzer for the Diagnosis of Human Immunodeficiency Virus.

Uettwiller-Geiger DL, Lessig M, An J, Barsch T, Smith S, Walker S, Riedel A, Hao Y, Mohammad AA.

Am J Clin Pathol. 2019 Mar 1;151(4):377-385. doi: 10.1093/ajcp/aqy153.

2.

Infection preventionists and laboratorians: Case studies on successful collaboration.

Spencer M, Uettwiller-Geiger D, Sanguinet J, Johnson HB, Graham D.

Am J Infect Control. 2016 Sep 1;44(9):964-8. doi: 10.1016/j.ajic.2016.02.011. Epub 2016 Apr 11.

PMID:
27079246
3.

Analytical characteristics of a biomarker-based risk assessment test for acute kidney injury (AKI).

Uettwiller-Geiger DL, Vijayendran R, Kellum JA, Fitzgerald RL.

Clin Chim Acta. 2016 Apr 1;455:93-8. doi: 10.1016/j.cca.2016.01.012. Epub 2016 Jan 18.

4.

Demographic data for urinary Acute Kidney Injury (AKI) marker [IGFBP7]·[TIMP2] reference range determinations.

Chindarkar NS, Chawla LS, Straseski JA, Jortani SA, Uettwiller-Geiger D, Orr RR, Kellum JA, Fitzgerald RL.

Data Brief. 2015 Nov 5;5:888-92. doi: 10.1016/j.dib.2015.10.036. eCollection 2015 Dec.

5.

Reference intervals of urinary acute kidney injury (AKI) markers [IGFBP7]∙[TIMP2] in apparently healthy subjects and chronic comorbid subjects without AKI.

Chindarkar NS, Chawla LS, Straseski JA, Jortani SA, Uettwiller-Geiger D, Orr RR, Kellum JA, Fitzgerald RL.

Clin Chim Acta. 2016 Jan 15;452:32-7. doi: 10.1016/j.cca.2015.10.029. Epub 2015 Nov 10.

6.

Acute kidney injury: New biomarkers detect risk for this silent killer.

Uettwiller-Geiger DL, McPherson P.

MLO Med Lab Obs. 2015 Jul;47(7):22-3. No abstract available.

PMID:
26299144
7.

A primer on on-demand polymerase chain reaction technology.

Spencer M, Barnes S, Parada J, Brown S, Perri L, Uettwiller-Geiger D, Johnson HB, Graham D.

Am J Infect Control. 2015 Oct 1;43(10):1102-8. doi: 10.1016/j.ajic.2015.06.001. Epub 2015 Jul 18.

8.

Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers.

Hoste EA, McCullough PA, Kashani K, Chawla LS, Joannidis M, Shaw AD, Feldkamp T, Uettwiller-Geiger DL, McCarthy P, Shi J, Walker MG, Kellum JA; Sapphire Investigators.

Nephrol Dial Transplant. 2014 Nov;29(11):2054-61. doi: 10.1093/ndt/gfu292. Epub 2014 Sep 18.

9.

Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department.

Peacock F, Morris DL, Anwaruddin S, Christenson RH, Collinson PO, Goodacre SW, Januzzi JL, Jesse RL, Kaski JC, Kontos MC, Lefevre G, Mutrie D, Sinha MK, Uettwiller-Geiger D, Pollack CV.

Am Heart J. 2006 Aug;152(2):253-62.

PMID:
16875905
10.

A lab's strategy to reduce errors depends on automation.

Uettwiller-Geiger DL.

MLO Med Lab Obs. 2005 Dec;37(12):26, 28-9. No abstract available.

PMID:
16435774
11.

Multicenter evaluation of an automated assay for troponin I.

Uettwiller-Geiger D, Wu AH, Apple FS, Jevans AW, Venge P, Olson MD, Darte C, Woodrum DL, Roberts S, Chan S.

Clin Chem. 2002 Jun;48(6 Pt 1):869-76.

Supplemental Content

Loading ...
Support Center